A real world study of Guizhi and Longgu Muli Decoction in children with seasonal allergic rhinitis (Lung and Spleen Deficiency Syndrome)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033160

Enrollment

Unknown

Registered

2020-05-22

Start date

2020-08-01

Completion date

Unknown

Last updated

2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Guizhi and Longgu Muli Decoction group vs.traditional western medicine group:Nil

Eligibility

Sex/Gender

All

Age

3 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Western medicine children AR. 2. It conforms to the diagnostic standard of the deficiency of lung qi and spleen qi. 3. From 3 to 14 years old, male and female are not limited. 4. Children with seasonal AR. 5. The legal guardian of the child is clear and informed.

Exclusion criteria

Exclusion criteria: 1. Children with heart, brain, liver, kidney, digestive system and other serious diseases. 2. Children who are in the process of combining multiple drugs or nonstandard drugs, which may affect the efficacy observation of this study.

Design outcomes

Primary

Measure	Time frame
Symptom score in nose;Symptoms score of the eye;Physical score;AR children's quality of life score;TCM Syndrome Symptoms Score;	—

Secondary

Measure	Time frame
Eosinophil count of nasal secretion;Serological testing;Adverse event;	—

Countries

China

Contacts

Public ContactQi Shen

The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine

1543040814@qq.com+86 13838341370

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026